CleanSpark Valuation
Is CLSK * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CLSK * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CLSK * (MX$309.55) is trading below our estimate of fair value (MX$1196.48)
Significantly Below Fair Value: CLSK * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CLSK *?
Key metric: As CLSK * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is CLSK *'s PS Ratio? | |
---|---|
PS Ratio | 11.4x |
Sales | US$342.21m |
Market Cap | US$3.90b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 11.1x |
Enterprise Value/EBITDA | 19.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CLSK *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.8x | ||
688568 Geovis TechnologyLtd | 9.7x | 29.2% | CN¥30.4b |
YOU Clear Secure | 3.4x | 10.8% | US$3.6b |
BRZE Braze | 7.4x | 16.9% | US$3.9b |
ESMT EngageSmart | 10.6x | 20.5% | US$3.9b |
CLSK * CleanSpark | 11.4x | 37.2% | Mex$3.9b |
Price-To-Sales vs Peers: CLSK * is expensive based on its Price-To-Sales Ratio (11.4x) compared to the peer average (7.4x).
Price to Sales Ratio vs Industry
How does CLSK *'s PS Ratio compare vs other companies in the Global Software Industry?
248 Companies | Price / Sales | Estimated Growth | Market Cap |
---|---|---|---|
248 Companies | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Sales vs Industry: CLSK * is expensive based on its Price-To-Sales Ratio (11.4x) compared to the Global Software industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is CLSK *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 11.4x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CLSK *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$309.55 | Mex$446.96 +44.4% | 27.8% | Mex$607.19 | Mex$212.52 | n/a | 6 |
Nov ’25 | Mex$212.00 | Mex$443.58 +109.2% | 27.8% | Mex$602.60 | Mex$210.91 | n/a | 6 |
Oct ’25 | Mex$183.00 | Mex$433.75 +137.0% | 27.8% | Mex$589.24 | Mex$206.23 | n/a | 6 |
Sep ’25 | Mex$211.20 | Mex$440.36 +108.5% | 26.9% | Mex$572.30 | Mex$200.31 | n/a | 6 |
Aug ’25 | Mex$282.00 | Mex$442.97 +57.1% | 23.9% | Mex$548.00 | Mex$228.34 | n/a | 6 |
Jul ’25 | Mex$330.56 | Mex$440.57 +33.3% | 23.6% | Mex$548.81 | Mex$228.67 | n/a | 6 |
Jun ’25 | Mex$271.98 | Mex$392.28 +44.2% | 21.2% | Mex$504.36 | Mex$252.18 | n/a | 6 |
May ’25 | Mex$280.97 | Mex$383.55 +36.5% | 21.2% | Mex$493.13 | Mex$246.57 | n/a | 6 |
Apr ’25 | Mex$309.90 | Mex$385.13 +24.3% | 22.6% | Mex$498.73 | Mex$232.74 | n/a | 6 |
Mar ’25 | Mex$305.00 | Mex$255.85 -16.1% | 36.8% | Mex$459.50 | Mex$170.19 | n/a | 6 |
Feb ’25 | Mex$142.22 | Mex$204.54 +43.8% | 18.8% | Mex$244.75 | Mex$137.89 | n/a | 6 |
Jan ’25 | n/a | Mex$205.38 0% | 18.8% | Mex$245.76 | Mex$138.46 | n/a | 6 |
Dec ’24 | Mex$109.50 | Mex$172.83 +57.8% | 26.7% | Mex$240.76 | Mex$91.14 | n/a | 6 |
Nov ’24 | n/a | Mex$177.53 0% | 27.3% | Mex$249.37 | Mex$94.41 | Mex$212.00 | 6 |
Oct ’24 | n/a | Mex$191.73 0% | 14.6% | Mex$238.59 | Mex$170.42 | Mex$183.00 | 4 |
Sep ’24 | Mex$74.50 | Mex$191.73 +157.4% | 14.6% | Mex$238.59 | Mex$170.42 | Mex$211.20 | 4 |
Aug ’24 | Mex$104.00 | Mex$159.87 +53.7% | 22.9% | Mex$201.94 | Mex$100.97 | Mex$282.00 | 4 |
Jul ’24 | n/a | Mex$137.02 0% | 30.6% | Mex$205.53 | Mex$102.76 | Mex$330.56 | 4 |
Jun ’24 | n/a | Mex$139.44 0% | 30.6% | Mex$209.17 | Mex$104.58 | Mex$271.98 | 4 |
May ’24 | n/a | Mex$140.93 0% | 34.6% | Mex$218.22 | Mex$90.92 | Mex$280.97 | 4 |
Apr ’24 | n/a | Mex$139.93 0% | 38.3% | Mex$223.89 | Mex$93.29 | Mex$309.90 | 4 |
Mar ’24 | n/a | Mex$139.93 0% | 38.3% | Mex$223.89 | Mex$93.29 | Mex$305.00 | 4 |
Feb ’24 | n/a | Mex$158.05 0% | 38.5% | Mex$237.08 | Mex$98.78 | Mex$142.22 | 4 |
Jan ’24 | n/a | Mex$158.05 0% | 38.5% | Mex$237.08 | Mex$98.78 | n/a | 4 |
Dec ’23 | n/a | Mex$184.77 0% | 26.7% | Mex$237.56 | Mex$118.78 | Mex$109.50 | 3 |
Nov ’23 | n/a | Mex$184.77 0% | 26.7% | Mex$237.56 | Mex$118.78 | n/a | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Global Dominion Access
€401.9m
Provides integral services for business process efficiency and sustainability worldwide.
DOM N
€57.80
7D
0%
1Y
n/a
Open Text
US$10.1b
Provides information management software and solutions.
OTEX N
US$777.91
7D
0%
1Y
-6.6%
Amdocs
US$10.0b
Through its subsidiaries, provides software and services worldwide.
DOX N
US$1,456.43
7D
0%
1Y
n/a